REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka - Liubka Georgieva EOOD (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka - Liubka Georgieva EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Apteka - Liubka Georgieva EOOD is an enterprise in Bulgaria, with the main office in Pernik. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on 2007. It currently has a total number of 30 (2023) employees. From the latest financial highlights, Apteka - Liubka Georgieva EOOD reported a net sales revenue drop of 1.21% in 2021. A negative growth of 17.24% was recorded in its total assets. The net profit margin of Apteka - Liubka Georgieva EOOD increased by 0.69% in 2021.

Headquarters
zh. k. Moshino, ul. Lugansk 54
Pernik; Pernik; Postal Code: 2303

Contact Details: Purchase the Apteka - Liubka Georgieva EOOD report to view the information.

Basic Information
Total Employees:
Purchase the Apteka - Liubka Georgieva EOOD report to view the information.
Outstanding Shares:
Purchase the Apteka - Liubka Georgieva EOOD report to view the information.
Registered Capital:
Purchase the Apteka - Liubka Georgieva EOOD report to view the information.
Incorporation Date:
2007
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka - Liubka Georgieva EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-1.21%
Total operating revenue
-1.4%
Operating profit (EBIT)
106.49%
EBITDA
71.3%
Net Profit (Loss) for the Period
123.73%
Total assets
-17.24%
Total equity
-2.27%
Operating Profit Margin (ROS)
0.77%
Net Profit Margin
0.69%
Return on Equity (ROE)
9.1%
Debt to Equity Ratio
-0.12%
Quick Ratio
-0.03%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?